Standard Mammalian Cell Line Thawing and Recovery
Materials Required
Principle
Standard mammalian cell line thawing and recovery restores cryopreserved cells to active culture by rapidly warming frozen cells, diluting or removing cryoprotectant, and assessing whether cells regain viability, attachment, proliferation, and expected function[1][2][3]. Cryopreservation commonly uses permeating cryoprotectants such as DMSO to reduce freeze-thaw injury, but DMSO exposure can also produce dose- and time-dependent cytotoxicity, so post-thaw recovery should minimize unnecessary exposure while preserving cell recovery[3][4][5].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
Reagents and chemicals
• Complete culture medium is used to dilute thawed cells and support recovery after thawing[1][2].• DMSO-containing cryopreservation medium is commonly used for mammalian cells, with 10% DMSO frequently reported, although several studies show that lower DMSO concentrations can preserve selected cell types under validated conditions[2][3][5][6].
• Phosphate-buffered saline or compatible culture medium may be used during post-thaw handling when required by the validated workflow[1][2].
Antibodies, probes, dyes, or kits
• Trypan blue dye exclusion, flow cytometry viability staining, metabolic assays such as MTT, and lineage or functional assays can be used to measure post-thaw viability and recovery quality[1][2][6][7].• For experiments connected to ovalbumin-induced allergic airway inflammation, thawed mammalian cell lines should be validated for viability and expected assay function before use in downstream immune, cytokine, or co-culture experiments[1][2][7].
Equipment and instruments
• A 37°C water bath or validated dry thawing system is used for active thawing of cryopreserved cells[1][8].• A biosafety cabinet supports aseptic transfer and seeding, a centrifuge may be used when the protocol requires removal of DMSO-containing supernatant, and a CO2 incubator supports post-thaw culture recovery[1][2][8].
Experimental Procedure
Preparation Steps
• Prepare complete culture medium, labeled culture vessels, and the post-thaw viability assay before removing cryovials from cryostorage, because timing and standardized handling affect post-thaw recovery and reproducibility[1][2].• Pre-warm recovery medium when required by the cell-line culture system, and use a validated vessel format that allows assessment of attachment, morphology, and viability after recovery[1][2].
Operation Steps
• Remove the cryovial from cryostorage and thaw actively at 37°C until the frozen suspension is mostly liquefied; a published adipose-derived adult stem cell study used rapid thawing in a 37°C water bath with 1–2 minutes of agitation before resuspension in culture medium and 24-hour recovery culture[2].• Transfer the thawed cell suspension into complete culture medium and seed into an appropriate culture vessel; when DMSO removal is required, dilute and centrifuge the suspension before resuspending the cell pellet, recognizing that washing can reduce DMSO exposure but may also introduce cell loss depending on the cell product and workflow[1][2][9].
• Incubate recovered cultures under the validated conditions for the cell line, and assess recovery after an appropriate recovery interval such as 24 hours when using assays similar to those reported for post-thaw viability and morphology analysis[2].
Data Acquisition and Analysis
• Record immediate post-thaw viability, viable cell recovery, attachment or morphology after recovery culture, and, when relevant, proliferation or cell-type-specific function[1][2][6][7].• Interpret recovery by comparing thawed cells with an unfrozen or previously validated culture control when available, and do not rely on immediate viability alone because some studies measured apoptosis, metabolic activity, differentiation, or colony-forming function after thawing to evaluate cell quality more completely[2][6][7].
• For experiments supporting ovalbumin-induced allergic airway inflammation studies, use only recovered cultures that meet predefined viability and functional criteria before downstream stimulation, cytokine measurement, co-culture, or molecular analysis[1][2][7].
Troubleshooting
Problem: Low immediate post-thaw viability.
• Possible cause: Cryopreservation or thawing conditions caused freeze-thaw injury, osmotic stress, or inadequate cryoprotection.• Literature-supported solution: Verify the cryoprotectant formulation and thawing method, because successful cryopreservation depends on suitable cryoprotectant choice, controlled freezing principles, and active thawing procedures[1][2][3].
Problem: Viability decreases during recovery culture after apparently successful thawing.
• Possible cause: DMSO exposure can cause dose- and time-dependent cytotoxicity in some mammalian cells.• Literature-supported solution: Reduce unnecessary post-thaw DMSO exposure by dilution or validated washing, and confirm that the washing step does not reduce recovery below acceptable limits[4][9].
Problem: Cells survive but show poor attachment, proliferation, or function.
• Possible cause: Immediate membrane integrity does not fully represent post-thaw functional recovery.• Literature-supported solution: Include recovery-period readouts such as morphology, attachment, metabolic activity, proliferation, differentiation, or other cell-type-specific functional assays[2][6][7].
Verweise:
- [1]. Yokoyama WM, et al. Cryopreservation and thawing of cells. Curr Protoc Immunol. 2012;99:A.3G.1-A.3G.6. [Content Brief]
- [2]. Thirumala S, et al. Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev. 2010;19(4):513-522. [Content Brief]
- [3]. Whaley D, et al. Cryopreservation: an overview of principles and cell-specific considerations. Cell Transplant. 2021;30:963689721999617. [Content Brief]
- [4]. Tamagawa S, et al. N-acetylcysteine attenuates oxidative stress-mediated cell viability loss induced by dimethyl sulfoxide in cryopreservation of human nucleus pulposus cells: a potential solution for mass production. JOR Spine. 2022;5(4):e1223. [Content Brief]
- [5]. Awan M, et al. Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity? Regen Med. 2020;15(3):1463-1491. [Content Brief]
- [6]. Gilfanova R, et al. Reduced dimethyl sulfoxide concentrations successfully cryopreserve human hematopoietic stem cells with multi-lineage long-term engraftment ability in mice. Cytotherapy. 2021;23(12):1056-1062. [Content Brief]
- [7]. Gurruchaga H, et al. Cell microencapsulation and cryopreservation with low molecular weight hyaluronan and dimethyl sulfoxide. Bio Protoc. 2019;9(4):e3164. [Content Brief]
- [8]. Kilbride P, et al. Automated dry thawing of cryopreserved haematopoietic cells is not adversely influenced by cryostorage time, patient age or gender. PLoS One. 2020;15(10):e0240310. [Content Brief]
- [9]. Rodríguez L, et al. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion. 2005;45(9):1391-1397. [Content Brief]